Stockscreener 앱 받기
127.69
1.85%
-2.41
시간 외 거래:
127.83
0.14
+0.11%
전일 마감가:
$130.10
열려 있는:
$129.92
하루 거래량:
713.37K
Relative Volume:
0.70
시가총액:
$4.77B
수익:
$401.09M
순이익/손실:
$32.64M
주가수익비율:
135.84
EPS:
0.94
순현금흐름:
$-120.51M
1주 성능:
-0.69%
1개월 성능:
+3.03%
6개월 성능:
+92.02%
1년 성능:
-14.28%
1일 변동 폭
$125.10
$130.70
1주일 범위
$125.10
$136.63
52주 변동 폭
$55.00
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
명칭
Transmedics Group Inc
전화
(978) 552-0900
주소
200 MINUTEMAN ROAD, ANDOVER, MA
TMDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
127.69 | 4.77B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-22 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-29 | 재확인 | Needham | Buy |
| 2024-10-29 | 재확인 | Oppenheimer | Outperform |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-08-21 | 개시 | Needham | Buy |
| 2024-06-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-06-04 | 개시 | Stephens | Overweight |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2022-08-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2019-05-28 | 개시 | Canaccord Genuity | Buy |
| 2019-05-28 | 개시 | Cowen | Outperform |
| 2019-05-28 | 개시 | JP Morgan | Overweight |
| 2019-05-28 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Transmedics Group Inc 주식(TMDX)의 최신 뉴스
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.9%Should You Sell? - MarketBeat
TransMedics Group Inc (TMDX) Trading Down 8.65% on Jun 18 - GuruFocus
TransMedics (TMDX) Continues to Scale Innovation in Organ Transplant Care - Yahoo Finance
Investors in shares of TransMedics Group, Inc. (NASDAQ:TMDX) Announced by the Shareholders Foundation in Connection with Lawsuit - Newswire :) Press Release Distribution
Boasting A 18% Return On Equity, Is TransMedics Group, Inc. (NASDAQ:TMDX) A Top Quality Stock? - Yahoo Finance
Handelsbanken Fonder AB Decreases Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $150.00 at Oppenheimer - Defense World
TransMedics price target raised to $150 from $130 at Oppenheimer By Investing.com - Investing.com Canada
10 Best Growth Stocks to Buy According to Billionaires - Insider Monkey
TransMedics Group (TMDX) Sees Price Target Boost by Oppenheimer - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
(TMDX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Oppenheimer Adjusts Price Target for TransMedics (TMDX) to $150 - GuruFocus
Oppenheimer Adjusts Price Target for TransMedics (TMDX) to $150 | TMDX Stock News - GuruFocus
Oppenheimer Hikes TransMedics Group Price Target to $150 From $130, Maintains Outperform Rating - MarketScreener
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Handelsbanken Fonder AB Sells 72,000 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Rhumbline Advisers Sells 537 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Bought by GAMMA Investing LLC - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Insider Anil P. Ranganath Sells 686 Shares - MarketBeat
Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May - MarketBeat
Two Sigma Investments LP Purchases Shares of 12,523 TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
TransMedics at Goldman Sachs Conference: Strategic Growth and Challenges By Investing.com - Investing.com Nigeria
TransMedics at Goldman Sachs Conference: Strategic Growth and Challenges - Investing.com
TransMedics Group, Inc. (TMDX): A Bull Case Theory - Insider Monkey
Transcript : TransMedics Group, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - marketscreener.com
3 Medical Technology Stocks Outperforming in 2025 - MarketBeat
TransMedics: Data Points To Strong Second Quarter, But Beware Of The Second Half - Seeking Alpha
GAMMA Investing LLC Boosts Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
12,523 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Acquired by Two Sigma Investments LP - Defense World
Sugar Maple Asset Management LLC Invests $740,000 in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Wellington Management Group LLP Sells 139,337 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Invests $4.13 Million in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Given “Overweight” Rating at Piper Sandler - Defense World
3 High-Growth Stocks Traders Love and Investors Should Watch - The Globe and Mail
Piper Sandler Boosts TransMedics (TMDX) PT to $145, Keeps Overweight Rating - MSN
Nuveen Asset Management LLC Sells 98,195 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group's (TMDX) "Overweight" Rating Reiterated at Piper Sandler - MarketBeat
TransMedics Group (TMDX) Price Target Raised by Piper Sandler | - GuruFocus
Piper Sandler raises TransMedics stock price target to $145 By Investing.com - Investing.com Canada
TransMedics (TMDX) Price Target Increased by Piper Sandler | TMD - GuruFocus
TransMedics (TMDX) Price Target Increased by Piper Sandler | TMDX Stock News - GuruFocus
TransMedics Group, Inc. (NASDAQ:TMDX) Director Edward M. Basile Sells 5,000 Shares - MarketBeat
TransMedics Group Inc (TMDX) Shares Up 4.58% on Jun 3 - GuruFocus
TransMedics at 45th Annual William Blair: Transforming Organ Transplants - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
4 Analysts Have This To Say About TransMedics Group - Nasdaq
Transmedics Group Inc (TMDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Transmedics Group Inc 주식 (TMDX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Basile Edward M | Director |
May 27 '25 |
Option Exercise |
0.70 |
5,000 |
3,500 |
7,866 |
| Basile Edward M | Director |
May 27 '25 |
Sale |
126.45 |
5,000 |
632,250 |
2,866 |
0.54%
1.82%
자본화:
|
볼륨(24시간):